The use of Lexipafant in the treatment of acute pancreatitis

Advances in Experimental Medicine and Biology

Volumn 416, Issue , 1997, Pages 365-369

  McKay, C ^a   Curran, F J M ^a   Sharples, C E ^a   Young, C A ^a   Baxter, J N ^a   Imrie, C W ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; LEXIPAFANT; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUTROPHIL; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 0030939133     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (34)

1. Frey CF, Wong HN, Hickman D, Pullos T. Toxicity of haemorrhagic ascitic fluid associated with haemorrhagic pancreatitis. Arch Surg 1982;117:401-404.
2. Ohlssen K, Tegner H. Experimental pancreatitis in the dog. Demonstration of trypsin in ascitic fluid, lymph and plasma. Scand J Gastroenterol 1973;8:129-133.
3. Amundsen E, Ofstad E, Hagen P-O. Experimental acute pancreatitis in dogs. Hypotensive effect induced by peritoneal exudate. Scand J Gastroenterol 1968;3:659-664.
4. Balldin G, Ohlsson K. Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery 1979;85:451-6.
5. Wilson C, Shenkin A, Imrie C. Role of the protease-antiprotease balance in peritoneal exudate during acute pancreatitis. Br J Surg 1991;78:78-81.
6. Medical Research Council of the United Kingdom. Death from acute pancreatitis: Multicentre trial of glucagon and aprotinin. Lancet 1977;ii:632-635.
7. Imrie CW, Benjamin S, Ferguson JC, McKay AJ, MacKenzie I, O'Neill J, Blumgart LH. A single-centre double-blind trial of Trasylol in primary acute pancreatitis. Br J Surg 1978;65:337-341.
8. Leese T, Holliday M, Heath D, Hall AW, Bell PRF. Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 1987;74:907-911.
9. Leese T, Thomas WM, Holloday M, Attard A, Watkins M, Neoptolemos JP, Hall C. A multicentre controlled clinical trial of high-volume fresh frozen plasma in prognostically severe acute pancreatitis. Ann R Coll Surg Eng 1991;73:207-214.
10. Buchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockman F, Adler G, Gaus W, Rolle K, Beger HG and the German Pancreatic Study Group. Gabexate mesilate in human acute pancreatitis. Gastroenterology 1993;104:1165-1170
11. Bradley EL, Hall JR, Lutz J, Hamner L, Lattouf O. Haemodynamic consequences of severe pancreatitis. Ann Surg 1983;198:130-133.
12. Beger HG, Bittner R, Buchler M, Hess W, Schmitz JE. Haemodynamic data pattern in patients with acute pancreatitis. Gastroenterology 1986;90:74-79
13. Tracey KJ, Lowrey SF. The role of cytokine mediators in septic shock. Adv Surg 1990;23:21-56.
14. Braquet P, Paubert-Braquet M, Bourgain RH, Bussolino F, Hosford D. PAF cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischaemia and graft rejection. J Lipid mediators 1989;1:75-112.
15. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatology 1988;3:105-112.
16. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993;34:41-45.
17. Leser H-G, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J. Evaluation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 1991;101:782-785.
18. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992;33:1264-1267.
19. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal acute pancreatitis a consequence of excessive leucocyte stimulation? The role of tumour necrosis factor. Cytokine 1991;3:12-16.
20. Exley AR, Leese T, Holloday MP, Swann RA, Cohen J. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-1128
21. Kriegler M, Perez C, Defay K. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein. Ramifications for the complex physiology of TNFα. Cell 1988;53:45-53
22. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991;5:2567-2574.
23. James K, van de Haan J, Lens S, Farmer F. Preliminary studies on the interaction of TNFα and IFN with alpha 2 macroglobulin. Immunology Letters 1992;32:49-58.
24. McIntyre CA, Chapman K, Reeder S, Dorreen MS, Bruce L, Rodgers S, Hayat K, Schreenivasan T, Sheridan E, Hancock BW, Rees RC. Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants. Eur J Cancer 1992;28:58-63.
25. Blick M, Sherwin S, Rosenbum M et al Phase 1 study of recombinant tumour necrosis factor in cancer patients. Cancer Res 1987;47:2986-2989
26. McKay C, Baxter JN, Imrie CW. Systemic complications in acute pancreatitis are associated with increased cytokine release by monocytes. Digestion 1994;55:316-7.
27. Bonavida B, Mencia-Huerta JM, Braquet P. Effect of platelet activating factor (PAF) on monocyte activation and production of tumour necrosis factor (TNF). J Allergy Appl Immunol 1989;88:157-160.
28. Sun X, Hsueh W. Bowel necrosis induced by tumour necrosis factor in rats is mediated by platelet activating factor. J Clin Invest 1988;81:1328-1331.
29. Konturek SJ, Dembinski A, Konturek PJ, Warzecha Z, Jaworek J, Gustaw P, R Tomaszewska R, Stachura J. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut 1992;33:1268-1274.
30. Emanuelli G, Montrucchio G, Gaia E, Dughera L, Corvetti G, Gubetta L. Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Path 1989;134:315-326.
31. Zhou W, McOllum MO, Levine BA, Olson MS. Role of platelet activating factor in pancreatitis-associated lung injury in the rat. Am J Path 1992;140:971-979.
32. Dabrowski A, Gabryelcwicz A, Chyczewski L. The effect of platelet activating factor antagonist (BN 52021) on ceuelin-induced acute pancreatitis with reference to oxygen radicals. Int J Pancreatol 1991;8:1-11.
33. Guillermo A, Lopez Farre A, Gomez Garre DN, Novo C, Romeo JM, Braquet P, Lopez-Novoa JM. Role of platelet activating factor in haemodynamic derangements in an acute rodent pancreatic model. Gastroenterology 1992;102:181-187.
34. Chang SW, Fedderson CO, Henson PM, Voelkel NF. Platelet activating factor mediates haemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 1987;79:1498-1509.